rs200855945
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs200312707
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs1994321
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs1908557
|
|
Mood Disorders
|
T |
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs190783615
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs190662943
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs190544851
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs189864513
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs188843168
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs183124483
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs183042538
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs182377406
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs1548076
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs150175932
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs143934587
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs143405544
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs142641502
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs142484554
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs141746753
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs138472420
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs1375194
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs1322281
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs12068879
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs11924809
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |
rs117198528
|
|
Mood Disorders
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
|
27622933 |
2016 |